Shin, J. E., Jung, H. A., Park, S., Sun, J., Lee, S., Ahn, J. S., Ahn, M., Shim, B. Y. (2025). Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer. Scientific Reports. https://doi.org/10.1038/s41598-024-81704-4